专题：2026亚布力论坛年会
3月18日消息，2026亚布力论坛年会于3月17日-19日在黑龙江亚布力举办。中国工程院院士、中华医学会副会长杨宝峰表示，总的来讲，生物医药发展的前景可以说是在健康领域，未来是在慢病、恶性肿瘤，还有心脑血管系统疾病、呼吸系统疾病等，但是需要多学科交叉，AI也是助手。
关于生物医药的发展和前景，杨宝峰谈到，利用计算机辅助设计和人工智能等技术，设计并开发具有多靶点、多重生物活性以及个体化的创新生物医药；着力提升原始创新、促进跨学科融合、针对基础研究薄弱痛点开展核心技术攻关；开发智能递送系统，提高生物医药的生物活性、稳定性和靶向性；加强专利成果落地转化，引导医药企业开展差异化创新，减少同质化竞争；建立覆盖全产业链（集政府、高校、科研机构、医药企业）的生物医药创新生态系统，促进科技链、产业链与人才链的全融合。
责任编辑：杨赐
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.